Firefly Neuroscience AIFF
NASDAQ AIFF
$0.94 +0.03 (+3.12%)
As of: Nov 9, 2026 · 12:40 PM EST

Firefly Neuroscience (AIFF) Gains (Losses) on Sale of Assets & Investments (2023)

Updated

Firefly Neuroscience (AIFF) reported Non Operating Investment Income of $382,525 for FY2023.

Analysis

Firefly Neuroscience (AIFF) Gains (Losses) on Sale of Assets & Investments (2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gains on Sales (Qtr)
1 Thermo Fisher Scientific 262.46 Bn 238.97 Bn 5.13 Bn -
2 Abbott Laboratories 191.35 Bn 165.22 Bn 7.39 Bn -
3 Danaher 164.03 Bn 143.68 Bn 3.84 Bn -
4 Intuitive Surgical 161.00 Bn 141.29 Bn 2.08 Bn -
5 Medtronic 132.16 Bn 97.42 Bn 6.34 Bn -
6 Stryker 125.35 Bn 111.53 Bn 4.25 Bn -
7 Boston Scientific 63.94 Bn 59.37 Bn 3.43 Bn -
8 Edwards Lifesciences 60.08 Bn 43.28 Bn 1.35 Bn -
9 Becton Dickinson 59.20 Bn 56.35 Bn 2.32 Bn -
10 Firefly Neuroscience 19.31 Mn -112,089.28 253,000.00 -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 382,525.00
API Access

Firefly Neuroscience Gains (Losses) on Sale of Assets & Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=AIFF&period=max&api_key=YOUR_API_KEY